IDH2 and astrocytoma (excluding glioblastoma): Unlike oligodendrogliomas and glioblastomas, which both frequently feature mutations in the promoter region of TERT to maintain telomere length, IDH-mutant astrocytomas frequently have mutations in ATRX, promoting an alternative lengthening of telomere (ALT) phenotype [152, 235].